Reading the whole genome of hundreds of individual healthy bowel glands from 42 people found that about one in a hundred already carries a cancer-driving mutation by middle age. Polyps and cancers are the rare survivors of a process happening everywhere in the bowel lining.
Whole-genome sequencing was used to analyse hundreds of normal crypts from 42 individuals. Signatures of multiple mutational processes were revealed: some ubiquitous and continuous, others found only in some individuals, in some crypts or during certain periods of life. Probable driver mutations were present in around 1% of normal colorectal crypts in middle-aged individuals, indicating that adenomas and carcinomas are rare outcomes of a pervasive process of neoplastic change across morphologically normal colorectal epithelium. Colorectal cancers showed substantially increased mutational burdens relative to normal cells.
It sets the baseline the adenoma-carcinoma sequence starts from and warns against reading a driver mutation found in tissue, or in stool or blood, as evidence of cancer.
Shares Mutagenesis & mutational signatures, Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.
Shares Field cancerisation, Mutagenesis & mutational signatures, Mutational signature, Clonal evolution & minimal residual disease.
Shares Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.
Shares Mutagenesis & mutational signatures, Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.
Shares APC, Clonal evolution & minimal residual disease, Driver mutation, KRAS.
Shares Mutagenesis & mutational signatures, Mutational signature, Clonal evolution & minimal residual disease, Whole-exome & whole-genome sequencing.
Shares Clonal evolution & minimal residual disease, Nature, Whole-exome & whole-genome sequencing.